Metabolic monitoring of second-generation antipsychotics: Evaluation of a pharmacist- and nurse-driven protocol

Exploring the Significance of Pharmaceutical Care in Mental Health: A Spotlight on Cannabis

“…Through actions like these, pharmacists play an active and relevant role in comprehensive mental healthcare, integrating with different sectors to promote a unified and effective approach. With a focus on the patient, they can contribute significantly to improving the mental health of the community as a whole, guiding, supporting, and educating those who face challenges in this area, including those seeking treatment with Cannabis as a medicine [ 63 ]. Pharmaceutical care is the basis for ensuring the safe and effective administration of Cannabis , providing therapeutic benefits without the risks associated with self-medication and inappropriate use [ 51 ].…”

Filling a global gap in access to critical mental health services: Engaging pharmacists to enhance the care of individuals with mental health needs and illnesses

“…Journal of the American Pharmacists Association j o u r n a l h o m e p a g e : w w w .j a p h a . o r g medication safety and use 16,17 and support pharmacists' intentions to engage in antidepressant monitoring as the best predictor of pharmacist systematic antidepressant monitoring behaviors. 18 As suggested by these researchers, intention may be influenced by pharmacists feeling capable to perform the services.…”

“…The final key theme focuses on the factors associated with medication management processes and outcomes for individuals with mental illness. Articles in this theme demonstrated how pharmacist-led interventions can improve psychotropic medication safety and use 16 , 17 and support pharmacists’ intentions to engage in antidepressant monitoring as the best predictor of pharmacist systematic antidepressant monitoring behaviors. 18 As suggested by these researchers, intention may be influenced by pharmacists feeling capable to perform the services.…”

Guidelines versus practice in screening and monitoring of cardiometabolic risks in patients taking antipsychotic medications: where do we stand?

“…Previously, a preliminary study demonstrated pharmacists’ ability to contribute to the cardiometabolic risk assessment and monitoring of patients prescribed antipsychotics. 13 In another study of pharmacist-led cardiovascular risk-reduction strategy in the USA, pharmacists were able to identify patients with SMI at high risks of cardiovascular issues by closely reviewing their lab profiles and make appropriate decisions, including starting medications and ordering relevant laboratory tests. 15 These findings revealed the capability of pharmacists in performing appropriate screening of patients with SMI as they demonstrated fair competency to make decisions and order laboratory tests for general comorbidities such as diabetes in patients with SMI when necessary.…”